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Melanoma is a highly metastatic tumour and its inci-
dence has ranked 5
th and 6
th among the most common
cancer afflicting both men and women. Melanoma cells
have a diminished antioxidant potential compared to
normal melanocytes, which leads to an accumulation of
ROS [1]. 1,4-benzopyrone heterocyclic compounds are
widely distributed in plants and are reported to exhibit
several biological roles, including antioxidant and free
radical scavenging [2], displaying a variety of pharmaco-
logical properties such as anti-inflammatory and antitu-
mour [3]. The present study aimed to assess the
response of the melanotic human skin melanoma
(A375) cell line to treatment with 8 different benzo-
pyran derivatives (eg. fisetin, luteolin and quercetin) - in
the concentration range 12.5 - 100µM, for 24, 48 and
72h incubation periods (using the MTT assay). Reversi-
bility of the drug effect (after 3 days) was also tested.
Concomitantly, similar experiments were carried out for
non-neoplasic, non-immortalised, human foreskin fibro-
blasts (BJ).
The results thus gathered allowed to conclude that the
chromone derivatives are promising chemopreventive
and/or chemotherapeutic agents towards melanoma,
while having no considerable adverse effect against
healthy cells.
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